Basmisanil
Unknown / undisclosed
Evidence outlook
Mid- and late-stage studies completed
This drug has completed mid- or late-stage studies. Where a sponsor has not posted registry results, topline data typically arrives via company announcements; see News.
Development in Schizophrenia stopped as a strategic decision by the sponsor. Development continues in another indication. Source
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
NCT02953639 NCT02953639 · Schizophrenia Registry: NCT02953639 | 2 | Change From Baseline to Week 24 in MATRICS Consensus Cognitive Battery (MCCB) Neurocognitive Composite Score (Baseline up to Week 24) 2019-12-12 | Change From Baseline to Week 24 in MATRICS Consensus Cognitive Battery (MCCB) Neurocognitive Composite Score (Baseline up to Week 24): Placebo — Baseline: 32.5 Composite T-Score (Standard Deviation 14.47); Week 12 Day 84: -0.17 Composite T-Score (Standard Deviation 5.07); Week 24 Day 168: 1.08 Composite T-Score (Standard Deviation 5.78) | Basmisanil 240mg BID — Baseline: 32.36 Composite T-Score (Standard Deviation 11.44); Week 12 Day 84: -0.28 Composite T-Score (Standard Deviation 6.08); Week 24 Day 168: 1.36 Composite T-Score (Standard Deviation 4.8) | not yet graded | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 2 (4)
What this study did
What this study did
What this study did
What this study did
Phase 1 (1)
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Basmisanil to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.